Skip to main content
Contact Us

The best investors see the bigger picture

Blackstone is the leading provider of private market solutions for individual investors [ 1 ]

Eligible investors can access institutional-quality private market solutions to help pursue specific objectives, such as capital appreciation, income generation, diversification, inflation protection, and tax advantages.

QTS Exterior Logo Scrubbed

Access the largest owner of commercial real estate globally [ 2 ]

Blackstone Real Estate Income Trust (BREIT) gives income-focused investors access to private real estate. View Prospectus

Annualized Inception to Date Return Class I [ 3 ]

9.2%

Learn More
Mountains

Invest with one of the premier private credit managers [ 4 ]

Blackstone Private Credit Fund (BCRED) is an institutional-quality private credit solution for income-focused investors. View Prospectus

Annualized Inception to Date Return Class I [ 5 ]

10.2%

Learn More

Unlock the power of Blackstone Credit in a single fund

Blackstone Private Multi-Asset Credit and Income Fund (BMACX) is a one-stop, multi-asset credit solution designed to access Blackstone’s leading Credit platform.

Learn More
Landscape with Road

Explore the world’s largest private equity platform [ 6 ]

Blackstone private equity is the number one platform with the broadest and deepest set of capabilities. Our staying power, drawn from the scale and breadth of the platform we’ve grown over 35 years, helps our companies withstand market cycles and succeed for the long term.

Learn More

Discover Blackstone’s premier infrastructure platform

Blackstone has deep infrastructure investment capabilities with a proven track record. Blackstone’s infrastructure platform invests across high-conviction themes, such as digital, transportation, and energy.

Learn More
Blackstone Private Wealth
Blackstone Private Wealth

Blackstone harnesses the power of private market investments for individual investors. To learn more, visit our dedicated site for financial advisors.

Learn More
PWS Bridge

As an investor in a rapidly evolving world, getting ahead of megatrends is essential. At Blackstone, we believe we are uniquely positioned to identify and capture these opportunities with our people, processes and years of experience combined with the scale and scope of our capital.

Artificial Intelligence

Artificial Intelligence

Power

Digital Economy

Life Sciences

    • Cloud computing, content creation, and the AI revolution are driving rapid growth in data.

    • Between 2010 and 2025, data created, consumed, and stored is expected to increase 101x. [ 7 ]

    • All of this data needs a place to live, which in turn has unlocked enormous need for data centers.

    Global Data Created, Consumed, and Stored Grew 101x [ 7 ]
    In Zettabytes

    Making the Connection: Social Media and Cloud Adoption, 2010,2, 2011-2015; Streaming and Content Creation, 2015-2021; Artificial Intelligence, 2022-2025E, 2025E, 202; 101x increase
    Making the Connection: Social Media and Cloud Adoption, 2010,2, 2011-2015; Streaming and Content Creation, 2015-2021; Artificial Intelligence, 2022-2025E, 2025E, 202; 101x increase

    • After 20 years of flat demand, power consumption is surging.

    • A 40% increase is projected over the next decade driven by AI, digitalization, and manufacturing. [ 9 ]

    • We estimate that meeting this demand will require a 6x increase in construction of new power generation and transmission capacity to keep pace. [ 10 ]

    • Connecting just the current energy projects in the US transmission queue to the grid is estimated to cost ~$4T, presenting a significant opportunity for private capital. [ 11 ]

    US Electricity Demand Projected to Grow 40% in the Next Decade [ 8 ]
    In Terawatt Hours

    Pending
    Pending

    • E-commerce growth has been a powerful tailwind for logistics real estate.

    • The migration of retail sales from brick‐and‐mortar stores to online platforms has big implications for warehouses, changing their utility and role in the global economy.

    • Blackstone spotted this trend early, growing our portfolio from less than 1% of our real estate equity portfolio pre-GFC to ~40% today—Blackstone is the largest private owner of warehouses in the world.

    US E-commerce Retail Sales Grew Nearly 10x [ 12 ]

    Pending
    Pending

    • Genomics, engineering and AI are advancing innovation in life sciences at an unprecedented pace, leading to the invention of many more potential medicines and medical devices than ever before.

    • Despite this progress, product development remains prohibitively expensive – averaging $2.6 billion per new medicine. [ 14 ]

    • 1 in 3 new therapies remain unfunded due to an estimated $172 billion annual funding gap.

    • We are helping to close this gap by collaborating with premier biopharma companies to fund breakthrough medicines and medical technologies, allowing them to reach patients who need them.

    Biopharma R&D Funding Gap Totals $172B Annually [ 13 ]

    Pending
    Pending
SAS tight Crop

“We’ve taken the same discipline and foresight that we’ve brought to institutional investors and built them into our partnership with financial advisors. There’s never been a better time to build wealth with Blackstone.”

Stephen A. Schwarzman

Chairman, CEO & Co-Founder





Investing involves risks, including loss of capital.

Where You Invest Matters

Important Disclosures

Past performance does not predict future returns. There can be no assurance that any Blackstone fund or investment will achieve its objectives or avoid substantial losses.

Informational Purposes Only
Forward-Looking Statements and Filings
View All
Blackstone data as of June 30, 2025. Market data sourced from public filings and fund websites, as of March 31, 2025, and is latest available for the peer set. Based on Blackstone’s analysis of publicly available data of the total net asset value (NAV) of alternative investment firms that offer solutions for individual (non-institutional) investors to invest in private equity, real estate, infrastructure, and private credit through U.S.-domiciled semi-liquid, perpetual private market funds (including non-traded REITs and non-traded BDCs). Blackstone’s analysis compares the total NAV as of March 31, 2025 for Blackstone’s non-traded REIT, non-traded BDC products, infrastructure and private equity vehicles for individual investors, to the total NAV as of March 31, 2025 of comparable products offered by alternative investment firms. This selection of alternative investment firms for comparison may not be representative of all in the category or sector. Private placement REIT and BDC products have been excluded from the dataset.
World’s largest owner of commercial real estate based on estimated market value per Real Capital Analytics, as of June 30, 2025.
As of July 31, 2025. Past performance does not predict future returns. The inception dates for the Class S, I, T and D shares are January 1, 2017, January 1, 2017, June 1, 2017 and May 1, 2017, respectively. The inception date for the Class S-2, T-2 and D-2 shares is August 5, 2025. The foregoing reflects the percent change in the NAV per share from the beginning of the applicable period, plus the amount of any distribution per share declared in the period. All returns shown assume reinvestment of distributions pursuant to BREIT’s distribution reinvestment plan, are derived from unaudited financial information, and are net of all BREIT expenses, including general and administrative expenses, transaction-related expenses, management fees, performance participation allocation, and share class-specific fees, but exclude the impact of early repurchase deductions on the repurchase of shares that have been outstanding for less than one year. Returns listed as (with sales load) reflect the returns after the maximum upfront selling commission and dealer manager fees. Returns listed as (no sales load) exclude upfront selling commissions and dealer manager fees. With sales load returns assume payment of the maximum upfront sales charge at initial subscription (3.5% for Class S, Class S-2, Class T and Class T-2 shares; 1.5% for Class D and Class D-2 shares). The sales charge for Class D shares became effective May 1, 2018. The sales charge for Class S-2, T-2, and D-2 shares became effective August 5, 2025. The returns have been prepared using unaudited data and valuations of the underlying investments in BREIT’s portfolio, which are estimates of fair value and form the basis for BREIT’s NAV. Valuations based upon unaudited reports from the underlying investments may be subject to later adjustments, may not correspond to realized value and may not accurately reflect the price at which assets could be liquidated. As return information is calculated based on NAV, return information presented will be impacted should the assumptions on which NAV was determined prove to be incorrect. Please see https://www.breit.com/performance, including “Use of Leverage”, for additional information about BREIT’s performance.
As of July 31, 2025. Based on Blackstone’s analysis of company earnings presentations and calls and latest publicly available data published by Blackstone’s peers.
As of July 31, 2025. Past performance does not predict future returns. Inception Date for Class I and S shares: January 7, 2021. Inception date for Class D shares: May 1, 2021. Total Net Return is calculated as the change in NAV per share during the period, plus distributions per share (assuming dividends and distributions are reinvested) divided by the beginning NAV per share. Returns greater than one year are annualized. All returns shown are derived from unaudited financial information and are net of all BCRED expenses, including general and administrative expenses, transaction related expenses, management fees, incentive fees, and share class specific fees, but exclude the impact of early repurchase deductions on the repurchase of shares that have been outstanding for less than one year. Inception-to-date (“ITD”) returns for the other class shares are as follows. Class S (without / with upfront placement fees or brokerage commissions) shares: 9.3%/8.4%; Class D (without / with upfront placement fees or brokerage commissions) shares: 9.5%/9.1%. Class S and Class D listed as (With Upfront Placement Fee or Brokerage Commissions) reflect the returns after the maximum upfront placement fees (3.5% for Class S and 1.5% for Class D). Class S and Class D listed as (No Upfront Placement Fee or Brokerage Commissions) excludes upfront placement fees. Class I does not have upfront placement fees. The returns have been prepared using unaudited data and valuations of the underlying investments in BCRED’s portfolio, which are estimates of fair value and form the basis for BCRED’s NAV. Valuations based upon unaudited reports from the underlying investments may be subject to later adjustments, may not correspond to realized value and may not accurately reflect the price at which assets could be liquidated. Please see https://www.bcred.com/performance, including “Use of Leverage”, for additional information about BCRED’s performance.
Private Equity International, as of June 2025, based on capital raised between January 1, 2011, and December 31, 2024.
International Data Corporation (IDC), as of May 2024. 2024 and 2025 represent year-end estimates.
EIA, as of November 2024 and NREL as of August 2022. Reflects total net electricity generation. Figures for 2024 and beyond reflect estimates.
EIA, as of November 2024 and NREL as of August 2022. Reflects total net electricity generation. Figures for 2024 and beyond reflect estimates.
GridStrategies, 2024.
S&P as of July 2024, and LevelTen Energy Report as of June 2024. Based on the fact that over 90% of the interconnection queue is renewables (wind and solar) and amount to $1.5B/GW to build in North America. Assumes 2600 gigawatts in the current transmission queue, per Lawrence Berkeley National Laboratory, as of April 2024.
US Census Bureau, as of March 31, 2025. Figures reflect trailing twelve-month values.
Evaluate Pharma and Morgan Stanley, as of January 2024. The annual funding gap is Blackstone’s estimate of the gap between the annual spread between the demand for medicine and device development capital and the supply of development capital from Biopharma and MedTech companies through R&D budgets.
Deloitte Analysis, 2022.